Screening of pancreatic cancer: Target population, optimal timing and how?
Bradley J. Waleleng, Randy Adiwinata, Nelly Tendean Wenas, Harlinda Haroen, Linda W. A. Rotty, Fandy Gosal, Luciana Rotty, Jeanne Winarta, Andrew Waleleng, Marcellus Simadibrata
Abstract
Pancreatic cancer patients usually present at a late stage due to subtle clinical manifestations. One of the most predictive prognostic factors in pancreatic cancer is the pancreatic cancer stage at diagnosis; therefore, early diagnosis is essential. Until now, pancreatic cancer screening has not become a standard practice for the general population due to the low incidence. In current circumstances, targeting individuals with a high risk of pancreatic cancer may be more rational. Several screening modalities for pancreatic cancer have also become debatable topics. Therefore, this article will review current evidence and recommendations regarding pancreatic screening cancer protocol in general and in high-risk populations.